These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 977210)

  • 1. Photochemotherapy (PUVA) and psoriasis: comparison of 8-MOP and 8-MOP/5-MOP.
    Langner A; Wolska H; Kowalski J; Duralska H; Murawska E
    Int J Dermatol; 1976 Nov; 15(9):688-9. PubMed ID: 977210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reappraisal of the use of 5-methoxypsoralen in the therapy of psoriasis.
    Calzavara-Pinton P; Ortel B; Carlino A; Honigsmann H; De Panfilis G
    Exp Dermatol; 1992 Jul; 1(1):46-51. PubMed ID: 1344660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Photochemotherapy in psoriasis.
    Warin AP; Carruthers JA
    Clin Exp Dermatol; 1976 Jun; 1(2):181-6. PubMed ID: 780009
    [No Abstract]   [Full Text] [Related]  

  • 4. 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis.
    Hönigsmann H; Jaschke E; Gschnait F; Brenner W; Fritsch P; Wolff K
    Br J Dermatol; 1979 Oct; 101(4):369-78. PubMed ID: 508604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet A (PUVA) sensitivity.
    Deeni YY; Ibbotson SH; Woods JA; Wolf CR; Smith G
    PLoS One; 2013; 8(9):e75494. PubMed ID: 24086543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoralen/UVA treatment and chromosomes. II. Analyses of psoriasis patients.
    Brøgger A; Waksvik H; Thune P
    Arch Dermatol Res; 1978 May; 261(3):287-94. PubMed ID: 686812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of psoriasis with psoralens and ultraviolet A. A double-blind comparison of 8-methoxypsoralen and 5-methoxypsoralen.
    Berg M; Ros AM
    Photodermatol Photoimmunol Photomed; 1994 Oct; 10(5):217-20. PubMed ID: 7880762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photochemotherapy of psoriasis with relevance to 8-methoxypsoralen plasma level and low intensity irradiation.
    Thune P; Volden G
    Acta Derm Venereol; 1977; 57(4):351-5. PubMed ID: 70930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased thymidine incorporation in circulating leukocytes after treatment of psoriasis with psoralen and long-wave ultraviolet light.
    Kraemer KH; Weinstein GD
    J Invest Dermatol; 1977 Aug; 69(2):211-4. PubMed ID: 881568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoralen-UVA-treated psoriatic lesions. Ultrastructural changes.
    Hashimoto K; Kohda H; Kumakiri M; Blender SL; Willis I
    Arch Dermatol; 1978 May; 114(5):711-22. PubMed ID: 646392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photochemotherapy (PUVA) of psoriasis using 3-carbethoxypsoralen, a non-carcinogenic compound in mice.
    Dubertret L; Averbeck D; Zajdela F; Bisagni E; Moustacchi E; Touraine R; Latarjet R
    Br J Dermatol; 1979 Oct; 101(4):379-89. PubMed ID: 389271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial photochemotherapy of psoriasis with orally administered 8-methoxypsoralen and longwave ultraviolet light (PUVA).
    Siddiqui AH; Cormane RH
    Br J Dermatol; 1979 Mar; 100(3):247-50. PubMed ID: 435382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte proliferation during PUVA therapy.
    Lischka G
    Arch Dermatol Res; 1979 Jun; 265(2):213-8. PubMed ID: 464663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experience with the 8-methoxypsoralen-UVA therapy (photochemotherapy) of psoriasis].
    Hofmann C; Plewig G; Braun-Falco O
    Hautarzt; 1976 Dec; 27(12):588-94. PubMed ID: 1010746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of resistant psoriasis with oral 8-methoxypsoralen and longwave ultraviolet light (PUVA). A treatment schedule and a follow-up study.
    Weismann K; Howitz J; Bro-Jorgensen A
    Acta Derm Venereol; 1977; 57(1):73-6. PubMed ID: 74173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of 8-methoxypsoralen kinetics: a relevant factor in the treatment of psoriasis by psoralen plus ultraviolet A therapy.
    Bonnot D; Béani JC; Boitard M; Reymond JL; Bériel H; Amblard P
    Photodermatol Photoimmunol Photomed; 1994 Feb; 10(1):33-7. PubMed ID: 8180098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
    Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of psoriasis (author's transl)].
    Ormea F
    MMW Munch Med Wochenschr; 1976 Jun; 118(25):811-6. PubMed ID: 819808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dark effect of 8-methoxypsoralen (8-MOP) on lymphocytes.
    Lischka G; Decker E
    Arch Dermatol Res; 1978 May; 261(3):267-72. PubMed ID: 686810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of psoriasis with a new micronized 5-methoxypsoralen tablet and UVA radiation.
    Aubin F; Makki S; Humbert P; Muret P; Agache P
    Arch Dermatol Res; 1994; 286(1):30-4. PubMed ID: 8141609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.